Risk of malaria in young children after periconceptional iron supplementation

Sabine Gies1,2, Stephen A Roberts3, Salou Diallo4

  • 1Department of Biomedical Sciences, Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium.

Maternal & Child Nutrition
|November 25, 2020
PubMed

Insights

Periconceptional iron supplementation did not impact child malaria risk or iron status in Burkina Faso. Maternal iron supplementation did not alter infant iron stores or malaria outcomes.

Area of Science:

  • Maternal and Child Health
  • Nutritional Epidemiology
  • Infectious Disease Research

Background:

  • Iron deficiency anemia is a significant global health issue, particularly affecting pregnant women and young children.
  • Periconceptional supplementation aims to improve maternal iron status before and during early pregnancy.
  • The impact of maternal iron supplementation on offspring malaria risk and iron status requires further investigation.

Purpose of the Study:

  • To investigate if offspring of young mothers receiving periconceptional iron supplementation have an increased risk of malaria.
  • To assess child iron biomarkers, nutritional status, anemia, and malaria outcomes in relation to maternal supplementation.
  • To evaluate antenatal iron biomarkers, preterm birth, fetal growth, and placental pathology.

Main Methods:

  • A randomized controlled trial in Burkina Faso assessed child safety and outcomes.
  • Child iron biomarkers, nutritional status, anemia, and malaria prevalence were measured.
  • Maternal iron biomarkers, placental pathology, gestational age, and fetal growth were assessed.

Main Results:

  • Infant iron biomarkers, anemia, and malaria outcomes did not differ between trial arms.
  • Factors associated with childhood parasitaemia included third trimester C-reactive protein, active placental malaria, and child body iron stores.
  • Chorioamnionitis was associated with a reduced risk of child parasitaemia.

Conclusions:

  • Periconceptional iron supplementation of young women did not alter their children's body iron stores.
  • Higher child body iron stores and placental malaria increased the risk of childhood parasitaemia.
  • Maternal iron supplementation did not appear to influence offspring malaria risk or iron status in this cohort.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
1.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
116
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
121